S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
LON:GNS

Genus Share Forecast, Price & News

GBX 4,828
+14.00 (+0.29%)
(As of 12/3/2021 04:45 PM ET)
Add
Compare
Today's Range
4,724
4,876
50-Day Range
4,726
5,750
52-Week Range
3,896
6,310
Volume
103,673 shs
Average Volume
97,175 shs
Market Capitalization
£3.18 billion
P/E Ratio
67.06
Dividend Yield
0.66%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive GNS News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.


Genus logo

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers. Genus plc has a strategic porcine collaboration with Beijing Capital Agribusiness Co. Ltd to research, develop, register, and market porcine reproductive and respiratory syndrome virus resistant pigs. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Headlines

Genus plc (LON:GNS) Insider Buys £44,960 in Stock
November 24, 2021 |  americanbankingnews.com
Liberum Capital Lowers Genus (LON:GNS) Price Target to GBX 5,740
November 24, 2021 |  americanbankingnews.com
Genus plc (LON:GNS) Given Average Recommendation of "Buy" by Analysts
November 14, 2021 |  americanbankingnews.com
Genus : Director/PDMR Shareholding
September 20, 2021 |  markets.businessinsider.com
Genus Share News (GNS)
September 15, 2021 |  lse.co.uk
Genus plc Reports Preliminary Results for the...
September 10, 2021 |  benzinga.com
Genus - Block listing Interim Review
August 4, 2021 |  proactiveinvestors.com
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
3,100
Year Founded
N/A

Sales & Book Value

Annual Sales
£574.30 million
Cash Flow
GBX 70.25 per share
Book Value
GBX 764.40 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£3.18 billion
Optionable
Not Optionable

Company Calendar

Ex-Dividend
11/18/2021
Today
12/05/2021
Dividend Payable
12/10/2021
Next Earnings (Estimated)
2/23/2022

MarketRank

Overall MarketRank

1.91 out of 5 stars

Analyst Opinion: 2.4Community Rank: 4.7Dividend Strength: 0.8Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Genus (LON:GNS) Frequently Asked Questions

Is Genus a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genus in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Genus stock.
View analyst ratings for Genus
or view top-rated stocks.

How has Genus' stock been impacted by COVID-19 (Coronavirus)?

Genus' stock was trading at GBX 3,472 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GNS shares have increased by 39.1% and is now trading at GBX 4,828.
View which stocks have been most impacted by COVID-19
.

When is Genus' next earnings date?

Genus is scheduled to release its next quarterly earnings announcement on Wednesday, February 23rd 2022.
View our earnings forecast for Genus
.

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus declared a dividend on Thursday, September 9th. Investors of record on Thursday, November 18th will be paid a dividend of GBX 21.70 per share on Friday, December 10th. This represents a dividend yield of 0.37%. The ex-dividend date of this dividend is Thursday, November 18th. This is a positive change from Genus's previous dividend of GBX 10.30. The official announcement can be seen at this link.
View Genus' dividend history
.

Is Genus a good dividend stock?

Genus pays an annual dividend of GBX 0.30 per share and currently has a dividend yield of 0.66%. The dividend payout ratio of Genus is 0.42%. This payout ratio is at a healthy, sustainable level, below 75%.
View Genus' dividend history.

What price target have analysts set for GNS?

5 brokers have issued 1 year price targets for Genus' shares. Their forecasts range from GBX 5,500 to GBX 5,740. On average, they expect Genus' share price to reach GBX 5,548 in the next twelve months. This suggests a possible upside of 14.9% from the stock's current price.
View analysts' price targets for Genus
or view top-rated stocks among Wall Street analysts.

Who are Genus' key executives?

Genus' management team includes the following people:
  • Mr. Stephen Wilson, CEO & Exec. Director (Age 61, Pay $1.57M)
  • Ms. Alison Henriksen, CFO & Exec. Director (Age 54, Pay $721.22k)
  • Dr. William Christianson, Chief Operating Officer
  • Dr. Elena Rice, Head of R&D and Chief Scientific Officer
  • Mr. Dan Hartley, Group Gen. Counsel & Company Sec.
  • Ms. Angelle R. Rosata, Group HR Director
  • Mr. Jerry Thompson, Chief Operating Officer of Genus ABS Beef
  • Dr. Nate Zwald, Chief Operating Officer of Genus ABS Dairy
  • Ms. Janet Duane, Group Financial Controller

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE) and Experian (EXPN).

What is Genus' stock symbol?

Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."

How do I buy shares of Genus?

Shares of GNS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Genus' stock price today?

One share of GNS stock can currently be purchased for approximately GBX 4,828.

How much money does Genus make?

Genus has a market capitalization of £3.18 billion and generates £574.30 million in revenue each year.

How many employees does Genus have?

Genus employs 3,100 workers across the globe.

What is Genus' official website?

The official website for Genus is www.genusplc.com.

Where are Genus' headquarters?

How can I contact Genus?

Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The company can be reached via phone at +44-1256-347100.


This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.